WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 377  372  366  360  354  298  256  211 
Births
Surviving infants
Pop. less than 5 years 29  29  28  27  27  28  28  25 
Pop. less than 15 years 80  81  81  81  83  87  83  78 
Female 15-49 years 105  104  103  102  100  84  70  55 

Number of reported case

(Click for retrospective incidence data for Bahamas (the))
Diphtheria
Japanese encephalitis
Measles 72  484 
Mumps
Pertussis 15 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bahamas (the))
Vaccine year result method % card seen                                                
BCG         
DTP1          100  99  99*  99*  100  99* 
DTP3          97  98  98  99  96  99  87  36 
HepB_BD         
HepB3          97  96  95  98  95 
Hib3          97  98  98  98  96  90 
JapEnc         
MCV          92  91  90  94  98  93  99 
MCV2          69  73  79  47  76 
PCV1          100  77  13 
PCV3          97  37 
Pol3          97  99  97  97  97  91  82  35 
Rota1         
Rota_last         
Rubella1          92  91  90  94  98 
TT2plus          98  97  95  96  96 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bahamas (the))
DTP1 99  99  99  99  99  99  95  61 
DTP3 97  98  98  99  96  99  86  36 
HepB3 97  96  95  98  95 
HepB_BD
Hib3 97  98  98  98  96  90 
MCV 92  91  90  94  98  93  86 
MCV2 69  73  79  78  76 
PAB 99  99  99  99  99  85  71 
PCV3 97  37 
Pol3 97  99  97  97  97  91  82  35 
Rota_last

Number of districts in the country 45  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 87
From 80 to 89% 11
From 50 to 79% 2
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 4, 6 months; No
DTaPHibIPV 2, 4, 6 months; No
DTwP 4-5 years;
DTwPHib 15 months; Yes
DTwPHibHep 2, 4, 6 months;
HPV From April 2014
HepB 2, 4, 6 months; Yes and 1st contact, +1, +6 months for adults
IPV 2, 4, 6 months; 4-5 years; Yes In the public sector given only to risk groups
Influenza Yes Infants, adults and risk groups
MMR 1, 4-5 years; Yes
OPV 2, 4, 6 months; 4-5 years; Yes
Pneumo_conj 2, 4, 6, 15 months; Yes
Rotavirus 2, 4 months; No
Td 10-12 years; Yes every 10 years
Tdap 10-12 years Yes every 10 years
Varicella 1, 4-5 years; Yes
YF travelers

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2020  2010-2020  2010-2015  2010-2012  2'012  2'012  2007-2015 
Nº of districts with microplans that include activities to raise immunization coverage number   10  10  85 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 45  91  91  31  31  31  85 
Nº districts with DTP3 coverage >=80% number 44  91  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 98  100  25 
Nº districts with measles (MCV1) coverage >=95% number 30  35  23       
% of districts with MCV1 coverage >=95% From 0 to 100% 67  38  25       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.